Browse > Article
http://dx.doi.org/10.7314/APJCP.2012.13.11.5415

Influence of Personal Character on Quality of Life of Patients with Esophageal Cancer in North Henan Province and Influencing Factors  

Lin, Jian-Ying (The First Affiliated Hospital of Xinxiang Medical University)
Wang, Ming-Sheng (The First Affiliated Hospital of Xinxiang Medical University)
Dong, Liang-Peng (The First Affiliated Hospital of Xinxiang Medical University)
Xu, Da-Wei (The First Affiliated Hospital of Xinxiang Medical University)
Wang, Ying (The First Affiliated Hospital of Xinxiang Medical University)
Li, Xue-Liang (The First Affiliated Hospital of Xinxiang Medical University)
Li, Xiu-Min (Nursing College, Xinxiang Medical University)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.13, no.11, 2012 , pp. 5415-5420 More about this Journal
Abstract
The aim of this study was to investigate QoL (quality of life) of patients with esophageal cancer in northern Henan province, China, and to accurate evaluate and reflect the relationship between patient characteristics and QoL. In the high risk area of esophageal cancer in the north of Henan province, 735 patients with esophageal cancer were investigated. The Eysenck personality questionnaire (EPQ) and QoL were analyzed by using the questionnaire of general situation, EPQ, QLQ-C30 and QLQ-OES18. The effects of personal character on the QoL of esophageal carcinoma patients were analyzed by SPSS 11.0 software. The QoL of esophageal cancer patients in Northern Henan region was significantly affected by character. The difference between choleric and type of melancholic temperament types was significant (P<0.01), also in OESEAT, OESTA, OESCO and OESSP (P<0.05). Differences in personal character can thus influence the quality of esophageal cancer patient lives.
Keywords
Esophageal cancer; quality of life; character;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Aaronson NK, Ahmedxai S (1993). The European Organixation for Research and Treament of Cencer QLQ-C30: A Qualityof-life Instrument for use in International Conocal Trials in Oncology. J Natl Cancer Inst, 85, 365.   DOI   ScienceOn
2 Apolone, G, Mosconi P (1998). Review of the concept of Quality of Life assesment and discussion of the present trend in clinical research. Nephrol Dial Transplant, 13, 65-9.
3 Blazeby JM, Brookes ST, Alderson D (2001). The prognostic value of quality of life scores during treatment for esophageal cancer. Gut, 49, 227-230.   DOI
4 Blazeby JM, Conroy T, Hammerlid E, et al (2003). Clinical and psychomet ric validation of an EORTC questionnaire module, the EORTC QLQ2OES18, to assess quality of life in patients with oesophageal cancer. Eur J cancer, 39, 1384-94.   DOI
5 Boer AG, van Lanschot JJ, van Sandick JW, et al (2004). Quality of life after transhiatal compared with extended transthoracic resection for adenocarcinoma of the esophagus. Clin Oncol, 22, 4202-8.   DOI   ScienceOn
6 Bottomley A (2002). The cancer patient and quality of life. Oncologist, 7, 120-5.   DOI
7 Cai YC, So CK, Nie AY, et al (2007). Characterization of genetic alteration patterns in human esophageal squamous cell carcinoma using selected microsatellite markers spanning multiple loci. Int J Oncol, 30, 1059-67.
8 Carlsson M, Strang P, Bjurstrom C (2000). Treatment modality affects long-term quality of life in gynecological cancer. Anticancer Res, 20, 563-8.
9 Carter JR, Chen MD, Fowler JM, Carson LF, Twiggs LB (1997). The effects of prolonged cycles of chemotherapy on quality of life in gynecological cancer patients. J Obstet Gynecol Res, 23, 197-203.   DOI   ScienceOn
10 Chan JA, Meyerhardt JA, Niedzwiecki D, et al (2008). Associstion of family history with cancer recurrence and survival among patients with Stag III colon cancer. JAMA, 299, 2515-23.   DOI
11 Collard JM, Otte JB, Reynaert M, Kestens PJ (1992). Quality of life three years or mopre after esophagectomy for cancer. Thorac Cardiovasc Surg, 104, 391-4.
12 Fayers PM, Aaronson NK, Bjordal K, et al (2001). On behalf of the EORTC quality of life study group. The EORTC QLQ-C30 scoring manual.3'd ed. Brussels: EORTC.
13 Greimel E, Thiel I, Peintinger F, Cegnar I, Pongratz E (2002). Prospective assessment of quality of life in gynecological cancer patients. Gynecol Oncol, 85, 140-7.   DOI
14 Holzner B, Kemmler G, Cella DK, et al (2004). Normative data for functional assessment of cancer therapy-general scale and its use for the interpretation of quality of life scores in cancer survivors. Acta Oncol, 43, 153-60.   DOI
15 Jonathan C, Jonas T (2003). Quality of life, functional outcome and Cost of early glottis cancer. Laryngoscope, 113, 67-8.
16 Luo N, Fones CS, Lim SE, et al (2005). The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-c30): validation of English version in Singapore. Qual Life Res, 14, 1181-6.   DOI   ScienceOn
17 Lagergren J, Lagergren P (2010). Oesophageal cancer. BMJ, 341, c6280.   DOI
18 Leplege A, Hunt S (1997). The problem of quality of life in medicine. JAMA, 278, 47-50.   DOI
19 Li XM, Zhao ZM, Chang TM, et al (2009). Clinicopathological features and hereditary susceptibility of patients with esophageal cancer in a high incidence area in China: an analysis of 1259 cases. World J Gastroenterol, 17, 2367-73.
20 Madhusudhan C, Saluja SS, Pal S, et al (2009). Palliative sending for relief of dysphasia in patients with inoperable esophageal cancer: impact on quality of life. Dis Esophagus, 22, 333-6.
21 Mercadante S, Fulfaro F, Casuccio A (2000). The impact of home palliative care on symptoms in advanced cancer patients. Support Care Cancer, 8, 307-10.   DOI
22 Ramage JK, Davies AH (2003). Measurement of quality of life in carcinoid neuroendocrine tumours. Endocr Relat Cancer, 10, 483-6.   DOI
23 Viklund P, Wengstrom Y, Rouvelas I, Lindblad M, Lagergren J (2006). Quality of life and persisting symptoms after oesophageal cancer surgery. Eur Cancer, 42, 1407-14.   DOI
24 Viola KV, Ariyan C, Sosa JA (2006). Surgical perspectives in gastrointestinal disease: a study of quality of life outcomes in esophageal, pancreatic, colon, and rectal cancers. World J Gastroenterol, 12, 3213-8.   DOI